Following actor Hayden Panettiere’s death at age 36 in South Carolina, skincare brand Neutrogena addressed mounting public backlash on Instagram regarding its past treatment of the star. Fans resurfaced a podcast interview where Panettiere claimed the company dropped her in 2015 after she spoke openly about her experience with postpartum depression.
In Plain English: The Clinical Takeaway
- Postpartum Depression (PPD): A mood disorder affecting roughly 1 in 7 women, characterized by extreme sadness, anger, trouble bonding with the baby, and insomnia, extending far beyond the typical “baby blues.”
The Backlash and Neutrogena’s Response
Panettiere worked as a global brand ambassador for Neutrogena from 2005 to 2015. In early 2015, following the birth of her daughter with ex-fiancé Wladimir Klitschko, she appeared on a morning talk show and discussed her struggles with postpartum depression. Shortly after that appearance, her long-standing partnership with the brand ended.
During an appearance on Jay Shetty’s “On Purpose Podcast” earlier in the year, Panettiere stated that the company attempted to fire her over those comments by invoking a contract morality clause. Her representative at the time contested the legality of the move, but the partnership was ultimately not renewed.
Following Panettiere’s death on Sunday at an apartment complex in South Carolina—where an autopsy was completed on Monday while the coroner’s office investigates the cause of death—social media platforms flooded with negative comments and calls for a boycott. Users targeted Neutrogena’s Instagram and Threads accounts, criticizing the brand’s historical handling of the situation.
On Thursday, Neutrogena issued a statement on Instagram acknowledging the controversy. According to the company, the brand understands it “made her feel unsupported during a very difficult time,” adding that “this is not what Neutrogena stands for or who we want to be.” The company stated it delayed its public statement out of respect for Panettiere’s family and loved ones, and pledged to make a significant investment in a long-standing community health partner to improve access to postpartum depression support.
Clinical Realities of Postpartum Mental Health
Postpartum depression remains one of the most common medical complications of childbirth, yet it is frequently misunderstood and underreported due to social stigma. According to clinical data from the Cleveland Clinic, PPD impacts 1 in 7 women.
| Condition | Estimated Prevalence | Key Diagnostic Indicators |
|---|---|---|
| Baby Blues | new mothers | Mild mood swings, tearfulness, anxiety; resolves within two weeks without clinical intervention. |
| Postpartum Depression (PPD) | 1 in 7 women | Severe sadness, intense irritability, sleep disturbances, difficulty bonding with infant, lasting beyond two weeks. |
Unlike transient mood fluctuations, clinical PPD disrupts daily functioning and requires structured therapeutic approaches.
Contraindications & When to Consult a Doctor
Self-medicating with alcohol or unprescribed substances—a struggle Panettiere openly discussed in her memoir, This Is Me: A Reckoning—is strictly contraindicated, as it can exacerbate depressive symptoms and negatively interact with prescribed psychotropic medications.
References
- Cleveland Clinic. Postpartum Depression: Statistics and Overview. Available via clinical health advisories.
- Panettiere, H. This Is Me: A Reckoning. Memoir detailing personal experiences with postpartum mental health and recovery.
- NBC News. “Neutrogena addresses backlash over its past brand deal with Hayden Panettiere.”
- CBC News. “Neutrogena responds after Hayden Panettiere fans renew call for boycott.”
Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
